Cargando…

Suppression of FOXM1 activities and breast cancer growth in vitro and in vivo by a new class of compounds

The transcription factor FOXM1 is upregulated and overexpressed in aggressive, therapy-resistant forms of hormone receptor-positive and triple negative breast cancers, and is associated with less good patient survival. FOXM1 signaling is also a key driver in many other cancers. Here, we identify a n...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ziegler, Yvonne, Laws, Mary J., Sanabria Guillen, Valeria, Kim, Sung Hoon, Dey, Parama, Smith, Brandi P., Gong, Ping, Bindman, Noah, Zhao, Yuechao, Carlson, Kathryn, Yasuda, Mayuri A., Singh, Divya, Li, Zhong, El-Ashry, Dorraya, Madak-Erdogan, Zeynep, Katzenellenbogen, John A., Katzenellenbogen, Benita S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884575/ https://www.ncbi.nlm.nih.gov/pubmed/31815181 http://dx.doi.org/10.1038/s41523-019-0141-7

Ejemplares similares

Suppression of Tumor Growth, Metastasis, and Signaling Pathways by Reducing FOXM1 Activity in Triple Negative Breast Cancer
por: Dey, Parama, et al.
Publicado: (2020)

Transcription Regulation and Genome Rewiring Governing Sensitivity and Resistance to FOXM1 Inhibition in Breast Cancer
por: Ziegler, Yvonne, et al.
Publicado: (2021)

Targeting the oncogenic transcription factor FOXM1 to improve outcomes in all subtypes of breast cancer
por: Katzenellenbogen, Benita S., et al.
Publicado: (2023)

The forkhead transcription factor FOXM1 promotes endocrine resistance and invasiveness in estrogen receptor-positive breast cancer by expansion of stem-like cancer cells
por: Bergamaschi, Anna, et al.
Publicado: (2014)

Macrophage-Elicited Loss of Estrogen Receptor Alpha in Breast Cancer Cells via Involvement of MAPK and c-Jun at the ESR1 Genomic Locus
por: Stossi, Fabio, et al.
Publicado: (2011)

Integrative genomics of gene and metabolic regulation by estrogen receptors α and β, and their coregulators
por: Madak-Erdogan, Zeynep, et al.
Publicado: (2013)

Integrative genomics of gene and metabolic regulation by estrogen receptors α and β, and their coregulators
por: Madak‐Erdogan, Zeynep, et al.
Publicado: (2017)

Transcriptomic analysis identifies gene networks regulated by estrogen receptor α (ERα) and ERβ that control distinct effects of different botanical estrogens
por: Gong, Ping, et al.
Publicado: (2014)

Pathway Preferential Estrogens Prevent Hepatosteatosis Due to Ovariectomy and High-Fat Diets
por: Zuo, Qianying, et al.
Publicado: (2021)

OR09-2 Pathway Preferential Estrogens Prevent Hepatosteatosis Due to Ovariectomy and High-Fat Diets
por: Zuo, Qianying, et al.
Publicado: (2019)

Reversal of endocrine resistance in breast cancer: interrelationships among 14-3-3ζ, FOXM1, and a gene signature associated with mitosis
por: Bergamaschi, Anna, et al.
Publicado: (2011)

FOXM1 regulates glycolysis and energy production in multiple myeloma
por: Cheng, Yan, et al.
Publicado: (2022)

OR12-07 Full Antagonism of Breast Cancer Cell Proliferation Can Result from Many Ligand-Induced Conformational Distortions of the Estrogen Receptor Ligand Binding Domain
por: Nwachukwu, Jerome, et al.
Publicado: (2020)

Estrogen receptor transcription and transactivation: Estrogen receptor alpha and estrogen receptor beta - regulation by selective estrogen receptor modulators and importance in breast cancer
por: S Katzenellenbogen, Benita, et al.
Publicado: (2000)

Coordinated activation of c-Src and FOXM1 drives tumor cell proliferation and breast cancer progression
por: Nandi, Ipshita, et al.
Publicado: (2023)

Tamoxifen down-regulation of miR-451 increases 14-3-3ζ and promotes breast cancer cell survival and endocrine resistance
por: Bergamaschi, Anna, et al.
Publicado: (2011)

Highly Sensitive Quantitative Imaging for Monitoring Single Cancer Cell Growth Kinetics and Drug Response
por: Mir, Mustafa, et al.
Publicado: (2014)

Defining the Energetic Basis for a Conformational Switch Mediating Ligand-Independent Activation of Mutant Estrogen Receptors in Breast Cancer
por: Mayne, Christopher G., et al.
Publicado: (2021)

Integration of Molecular Profiling and Chemical Imaging to Elucidate Fibroblast-Microenvironment Impact on Cancer Cell Phenotype and Endocrine Resistance in Breast Cancer
por: Holton, Sarah E., et al.
Publicado: (2014)

Highly Selective Salicylketoxime-Based Estrogen Receptor β Agonists Display Antiproliferative Activities in a Glioma Model
por: Paterni, Ilaria, et al.
Publicado: (2015)

Long-Term Administration of Conjugated Estrogen and Bazedoxifene Decreased Murine Fecal β-Glucuronidase Activity Without Impacting Overall Microbiome Community
por: Chen, Karen Lee Ann, et al.
Publicado: (2018)

OR11-01 A New Model for Estrogen Receptor-alpha Antagonist Mechanism of Action
por: Nwachukwu, Jerome C, et al.
Publicado: (2023)

Expanding Our Scope and Our Identity
por: Erdogan, Zeynep Madak, et al.
Publicado: (2022)

THU558 Combination Therapy Of Acetyl-CoA Synthetase Inhibitor And Fulvestrant Reverse Epigenetic Alterations Of Metastatic Breast Cancer Cells And Reduce Cancer Cell Proliferation
por: Mogol, Ayca N, et al.
Publicado: (2023)

Bazedoxifene and conjugated estrogen combination maintains metabolic homeostasis and benefits liver health
por: Chen, Karen Lee Ann, et al.
Publicado: (2017)

Racial differences in lifestyle, demographic, and health factors associated with quality of life (QoL) in midlife women
por: Smith, Brandi Patrice, et al.
Publicado: (2021)

Telomerase Induction in HPV Infection and Oncogenesis
por: Katzenellenbogen, Rachel
Publicado: (2017)

THU501 Examining The Link Between Exposure To Neighborhood Violence And PRMT6 And Glucocorticoid Receptor Binding To Chromatin In Lung Tumors
por: Heath, Hannah, et al.
Publicado: (2023)

Liquid biopsy: expanding the frontier of circulating biomarker discovery and validation in breast cancer
por: Miller, Philip C., et al.
Publicado: (2019)

Full Antagonism of the Estrogen Receptor without a Prototypical Ligand Side Chain
por: Srinivasan, Sathish, et al.
Publicado: (2016)

Respective role of membrane and nuclear estrogen receptor (ER) α in the mandible of growing mice: Implications for ERα modulation
por: Vinel, Alexia, et al.
Publicado: (2018)

The structural pervasiveness of estrogenic activity.
por: Katzenellenbogen, J A
Publicado: (1995)

PET Imaging Agents (FES, FFNP, and FDHT) for Estrogen, Androgen, and Progesterone Receptors to Improve Management of Breast and Prostate Cancers by Functional Imaging
por: Katzenellenbogen, John A.
Publicado: (2020)

Stringing along the estrogen receptor to engage with DNA
por: Katzenellenbogen, John A.
Publicado: (2023)

Combined Targeting of Estrogen Receptor Alpha and Exportin 1 in Metastatic Breast Cancers
por: Cotul, Eylem Kulkoyluoglu, et al.
Publicado: (2020)

Hyaluronan, Cancer-Associated Fibroblasts and the Tumor Microenvironment in Malignant Progression
por: McCarthy, James B., et al.
Publicado: (2018)

Corrigendum: Hyaluronan, Cancer-Associated Fibroblasts and the Tumor Microenvironment in Malignant Progression
por: McCarthy, James B., et al.
Publicado: (2018)

ODP563 Breast Cancer With Liver Metastasis Responds Poorly to Fulvestrant-Based Combination Therapy and Chemotherapy
por: Chien, Christine, et al.
Publicado: (2022)

Estrogen receptor alpha somatic mutations Y537S and D538G confer breast cancer endocrine resistance by stabilizing the activating function-2 binding conformation
por: Fanning, Sean W, et al.
Publicado: (2016)

Designer antiandrogens join the race against drug resistance
por: Josan, Jatinder S, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_a934vnl4rfrdusumgubm8b5lfl